HUMPHREY RACHEL — SEC insider filings
SEC reporting owner CIK 1579781. 9 insider filings on record with FilingPulse; latest filed 2026-11-06.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2020-09-10 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 15,496 shares, $15,917 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 13,896 shares @ $1.03 ($14,362) in Pyxis Oncology, Inc., filed 2026-03-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | Director | 7 | — | 3 legs · 15,496 sh · $15,917 | 6 |
| Black Diamond Therapeutics, Inc. (BDTX) | Chief Medical Officer | 2 | — | — | 3 |
Insider filings — HUMPHREY RACHEL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-06 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 34,500 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Pyxis Oncology, Inc. (PYXS) | Sale (S): 1,400 @ $0.97 · Sale (S): 200 @ $0.97 · Sale (S): 13,896 @ $1.03 | EDGAR |
| 2026-03-25 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 45,867 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 36,979 (derivative) @ $0.98 | EDGAR |
| 2024-03-28 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 38,741 @ $0 | EDGAR |
| 2023-03-28 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 58,064 @ $0 | EDGAR |
| 2022-08-15 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 236,220 (derivative) @ $0 | EDGAR |
| 2021-02-19 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-09-10 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 10,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579781 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs